Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patients' needs in proton therapy: A survey among ten European facilities.
Mazzola GC, Bergamaschi L, Pedone C, Vincini MG, Pepa M, Zaffaroni M, Volpe S, Rombi B, Doyen J, Fossati P, Haustermans K, Høyer M, Langendijk JA, Matute R, Orlandi E, Rylander H, Troost EGC, Orecchia R, Alterio D, Jereczek-Fossa BA. Mazzola GC, et al. Among authors: doyen j. Clin Transl Radiat Oncol. 2023 Aug 22;43:100670. doi: 10.1016/j.ctro.2023.100670. eCollection 2023 Nov. Clin Transl Radiat Oncol. 2023. PMID: 37736140 Free PMC article.
[Reirradiation of spine and lung tumor with CyberKnife].
Bondiau PY, Doyen J, Mammar H, Thariat J, Castelli J, Benezery K, Rucka G. Bondiau PY, et al. Among authors: doyen j. Cancer Radiother. 2010 Oct;14(6-7):438-41. doi: 10.1016/j.canrad.2010.06.011. Epub 2010 Aug 19. Cancer Radiother. 2010. PMID: 20724188 French.
Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance.
Brahimi-Horn MC, Ben-Hail D, Ilie M, Gounon P, Rouleau M, Hofman V, Doyen J, Mari B, Shoshan-Barmatz V, Hofman P, Pouysségur J, Mazure NM. Brahimi-Horn MC, et al. Among authors: doyen j. Cancer Res. 2012 Apr 15;72(8):2140-50. doi: 10.1158/0008-5472.CAN-11-3940. Epub 2012 Mar 2. Cancer Res. 2012. PMID: 22389449
Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature.
Gérard JP, Baulieux J, Doyen J, Gal J, Letouze E, Olschwang S, Chapet O, Romestaing P. Gérard JP, et al. Among authors: doyen j. Cancer Radiother. 2012 Dec;16(8):688-96. doi: 10.1016/j.canrad.2012.09.003. Epub 2012 Nov 13. Cancer Radiother. 2012. PMID: 23153504
143 results